Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance

BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://www.ncbi.nlm.nih.gov/pubmed/29605979
http://dx.doi.org/10.5056/jnm16111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://www.ncbi.nlm.nih.gov/pubmed/29605979
http://dx.doi.org/10.5056/jnm16111

Ejemplares similares